NCT04304963
- Conditions
- Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +8 more
- Locations
-
- King's College London London, United Kingdom
Clinical trial condition
Diabetes Mellitus, Type 1
Explore clinical trials studying Diabetes Mellitus, Type 1. Study availability and eligibility vary by location and protocol.
2,861 public trials
319 recruiting studies
Diabetes Mellitus, Type 1 trial results
NCT05286450
- Conditions
- Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +5 more
- Locations
-
- Faculty of medicine Sohag University Sohag, Egypt
NCT06074965
- Conditions
- Autoimmune Diseases, Diabetes, Diabetes Mellitus, +7 more
- Locations
-
- Azienda Ospedaliera San Camillo Forlanini Roma, Italy
NCT04670198
- Conditions
- Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +5 more
- Locations
-
- Guy's and St Thomas' NHS Foundation Trust London, United Kingdom
- University Lewisham Hospital London, United Kingdom
- Queen Elizabeth Hospital London, United Kingdom
- King's College Hospital London, United Kingdom
NCT05067270
- Conditions
- Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +6 more
- Locations
-
- Profil Institut für Stoffwechselforschung Neuss, North Rhine-Westphalia, Germany
- Profil Mainz Mainz, Germany
NCT05806190
- Conditions
- Adrenal Gland Diseases, Adrenal Insufficiency, Autoimmune Diseases, +8 more
- Locations
-
- Charing Cross Hospital, Imperial College Healthcare NHS Trust London, United Kingdom
NCT06055829
- Conditions
- Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +5 more
- Locations
-
- Hisham Ibrahim Abu Dhabi, United Arab Emirates
NCT05370339
- Conditions
- Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +15 more
- Locations
-
- University of Colorado, Barbara Davis Center Aurora, Colorado, United States
Completed
The Steno 780G Study
NCT04914910
- Conditions
- Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +6 more
- Locations
-
- Steno Diabetes Center Copenhagen Gentofte Municipality, Denmark
Completed
Afrezza® Dosing Optimization Study
NCT04849845
- Conditions
- Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +13 more
- Locations
-
- AMCR Institute Escondido, California, United States
- Diablo Clinical Research Walnut Creek, California, United States